Serum MiR-181d-5p Levels in Response to Controlled Ovarian Stimulation: Predictive Value and Biological Function

Overview

Journal JBRA Assist Reprod

Specialty Reproductive Medicine

Date 2023 Mar 23

PMID 36952624

Authors

Maria Gabriela F Mulato

Luana Marianni Hercolin

Daniela P A F Braga

Amanda S Setti

Rita de Cassia S Figueira

Lais Rosa Viana

Carla De Moraes Salgado

Maria Cristina Cintra Gomes Marcondes

Edson Borges Jr

Murilo Vieira Geraldo

Affiliations

Soon will be listed here.

Abstract

The response to controlled ovarian stimulation (COS) for in vitro fertilization (IVF) varies dramatically from one patient to another, affecting success rates. A previous large-scale study identified increased serum miR-181d-5p levels in patients with high response to COS prior to stimulation. We aim to evaluate whether the expression of miR-181d-5p differs according to the ovarian response to COS in women undergoing intracytoplasmic sperm injection (ICSI) cycles. Samples collected prior to COS for ICSI were split into three groups depending on the ovarian response to COS: poor response (PR), <4 oocytes retrieved (n=25); normal response (NR), ≥8 and ≤12 oocytes retrieved (n=21); and high response (HR), >25 oocytes retrieved (n=20). miR-181d-5p serum levels were compared among experimental groups. miR-181d-5p levels were increased in the HR group when compared to the PR (p=0.0001) and NR groups (p=0.0079). miR-181d-5p levels correlated with the number of aspirated follicles (p<0.0001), retrieved oocytes (p<0.0001), and mature oocytes (p=0.0002). Increased miR-181d-5p levels independently predict a high response (p=0.006), with Positive and Negative Predictive Values of 66.7% and 69.4%, respectively. miR-181d-5p was also detected in the ovarian tissue in a mouse model. Moreover, computational analysis of miR-181d-5p predicted targets and promoter region suggested that this miRNA might be involved in the regulation of key signaling pathways and biological processes for female reproductive biology. In conclusion, miR-181d-5p is a promising circulating predictor of high stimulation and potential mediator of the hypothalamus-pituitary-gonad axis, providing opportunities for the individualization of COS protocols.

References

Scalici E, Traver S, Mullet T, Molinari N, Ferrieres A, Brunet C . Circulating microRNAs in follicular fluid, powerful tools to explore in vitro fertilization process. Sci Rep. 2016; 6:24976. PMC: 4840336. DOI: 10.1038/srep24976. View

Otsuka F, Shimasaki S . A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis. Proc Natl Acad Sci U S A. 2002; 99(12):8060-5. PMC: 123020. DOI: 10.1073/pnas.122066899. View

Santonocito M, Vento M, Guglielmino M, Battaglia R, Wahlgren J, Ragusa M . Molecular characterization of exosomes and their microRNA cargo in human follicular fluid: bioinformatic analysis reveals that exosomal microRNAs control pathways involved in follicular maturation. Fertil Steril. 2014; 102(6):1751-61.e1. DOI: 10.1016/j.fertnstert.2014.08.005. View

Huang C, Weitsman S, Dykes B, Magoffin D . Stem cell factor and insulin-like growth factor-I stimulate luteinizing hormone-independent differentiation of rat ovarian theca cells. Biol Reprod. 2001; 64(2):451-6. DOI: 10.1095/biolreprod64.2.451. View

Lee W, Otsuka F, Moore R, Shimasaki S . Effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod. 2001; 65(4):994-9. DOI: 10.1095/biolreprod65.4.994. View

Mcgee E, Hsueh A . Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000; 21(2):200-14. DOI: 10.1210/edrv.21.2.0394. View

Lee K, Khivansara V, Santos M, Lamba P, Yuen T, Sealfon S . Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone beta subunit transcription. J Mol Endocrinol. 2007; 38(1-2):315-30. DOI: 10.1677/jme.1.02196. View

Nyboe Andersen A, Nelson S, Fauser B, Garcia-Velasco J, Klein B, Arce J . Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril. 2016; 107(2):387-396.e4. DOI: 10.1016/j.fertnstert.2016.10.033. View

Zhao C, Liu X, Shi Z, Zhang J, Zhang J, Jia X . Role of serum miRNAs in the prediction of ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients. Cell Physiol Biochem. 2015; 35(3):1086-94. DOI: 10.1159/000373934. View

10.

Polyzos N, Tournaye H, Guzman L, Camus M, Nelson S . Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2013; 100(2):430-7. DOI: 10.1016/j.fertnstert.2013.04.029. View

11.

Adamson G, de Mouzon J, Chambers G, Zegers-Hochschild F, Mansour R, Ishihara O . International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011. Fertil Steril. 2018; 110(6):1067-1080. DOI: 10.1016/j.fertnstert.2018.06.039. View

12.

Weber J, Baxter D, Zhang S, Huang D, Huang K, Lee M . The microRNA spectrum in 12 body fluids. Clin Chem. 2010; 56(11):1733-41. PMC: 4846276. DOI: 10.1373/clinchem.2010.147405. View

13.

Ferraretti A, La Marca A, Fauser B, Tarlatzis B, Nargund G, Gianaroli L . ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011; 26(7):1616-24. DOI: 10.1093/humrep/der092. View

14.

Shimasaki S, Moore R, Otsuka F, Erickson G . The bone morphogenetic protein system in mammalian reproduction. Endocr Rev. 2004; 25(1):72-101. DOI: 10.1210/er.2003-0007. View

15.

La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio A . Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2009; 16(2):113-30. DOI: 10.1093/humupd/dmp036. View

16.

Roth L, McCallie B, Alvero R, Schoolcraft W, Minjarez D, Katz-Jaffe M . Altered microRNA and gene expression in the follicular fluid of women with polycystic ovary syndrome. J Assist Reprod Genet. 2014; 31(3):355-62. PMC: 3947080. DOI: 10.1007/s10815-013-0161-4. View

17.

Patrizio P, Bianchi V, Lalioti M, Gerasimova T, Sakkas D . High rate of biological loss in assisted reproduction: it is in the seed, not in the soil. Reprod Biomed Online. 2007; 14(1):92-5. DOI: 10.1016/s1472-6483(10)60769-9. View

18.

Lukaszuk K, Kunicki M, Liss J, Lukaszuk M, Jakiel G . Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization. Eur J Obstet Gynecol Reprod Biol. 2013; 168(2):173-7. DOI: 10.1016/j.ejogrb.2013.01.013. View

19.

Benedetti R, Papulino C, Sgueglia G, Chianese U, De Marchi T, Iovino F . Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer. Cancers (Basel). 2021; 13(3). PMC: 7867078. DOI: 10.3390/cancers13030543. View

20.

Shimizu T, Kayamori T, Murayama C, Miyamoto A . Bone morphogenetic protein (BMP)-4 and BMP-7 suppress granulosa cell apoptosis via different pathways: BMP-4 via PI3K/PDK-1/Akt and BMP-7 via PI3K/PDK-1/PKC. Biochem Biophys Res Commun. 2012; 417(2):869-73. DOI: 10.1016/j.bbrc.2011.12.064. View